Robert Neely
About Robert Neely
Robert Neely is the Associate Director of Pharmacodiagnostics at Bristol-Myers Squibb, with extensive experience in research and diagnostics.
Title
Robert Neely is the Associate Director of Pharmacodiagnostics at Bristol-Myers Squibb. His role involves overseeing diagnostic strategies and contributing to the regulatory submission processes for in vitro diagnostic devices. He coordinates cross-functional teams to advance these diagnostic strategies.
Company
Robert Neely currently works at Bristol-Myers Squibb, a global biopharmaceutical company known for its innovation in discovering, developing, and delivering medicines for serious diseases. Neely has held several positions at this company, contributing to critical advancements in pharmacodiagnostics.
Education and Expertise
Robert Neely achieved his PhD in Immunology and Microbial Pathogenesis from Thomas Jefferson University Hospitals, completing his studies in 2010. He also undertook Non-Traditional Graduate Studies at the University of Pennsylvania from 2000 to 2002. Neely began his academic career at Rider University, where he earned a Bachelor of Science in Biology in 1999.
Career Background
Robert Neely's career spans various roles across leading institutions. He worked at Bristol-Myers Squibb as a Research Investigator, transitioning through multiple positions from 2010 to the present, including Senior Research Investigator and Research Investigator II. Prior to that, he was a graduate student at Thomas Jefferson University and a research technician at the University of Pennsylvania.
Achievements
Robert Neely has made significant contributions to the field of pharmacodiagnostics. He played a key role in the development and validation of ligand binding assays for pharmacodiagnostic applications and contributed to the regulatory submission process for in vitro diagnostic devices. Additionally, he has mentored junior scientists and researchers through the JCBS mentorship program.